According to the analysis of Reports and Data, the global Acute Respiratory Distress Syndrome Market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2026, at a CAGR of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body organs, which at the end impact the appropriate functioning of the parts. Various causes are included with the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in the airway.

According to a survey done by the World Health Organization (WHO), it is seen that more than 3 million people are effects due to acute respiratory distress syndrome. It can affect people of all ages. The main reason for the ARDS is air pollution, which is caused due to the emission by the vehicles. The harmful gases emitted are inhaled by the people thus leading to several problems.

Request a sample Report of Acute Respiratory Distress Syndrome (ARDS) Market @ https://www.reportsanddata.com/sample-enquiry-form/2089

Further key findings from the report suggest

• The market for acute respiratory distress syndrome is anticipated to grow at a CAGR of 8.3% in the Asia-Pacific, followed by North America and Europe, with 4.8% and 5.7% CAGR, respectively. Increasing chronic diseases and the rise in air pollution are the key factors to accelerate market growth during the forecast period across all regions.
• As of 2018, the therapeutic device segment was valued at USD 291.9 Million and is expected to grow at a CAGR of 5.8% during the forecast period. Increasing preference for gastrointestinal bleeding and pulmonary fibrosis has been one of the reasons for the growth of the acute respiratory distress syndrome market.
• Due to the ARDS, various complications related to the brain and lung are noticed. Neurological hypoxic brain damage is also one of the injury types, which is reported for acute respiratory distress syndrome.
• The treatment of acute respiratory distress syndrome is Fibro Proliferate, resolution stage, recovery stage, and many more.
• The Asia-Pacific is the largest region for the acute respiratory distress syndrome market due to the significant contribution from countries like China, Japan, India, and Korea due to the growing end-segment and sales channel industries.
• Asia Pacific region is accounted for the third largest market share in 2017, due to consumption in well establishes and end-user segment industries.
• Among the region, North America has the largest market share. The primary driver for the acute respiratory distress syndrome market in North America is the growing brain injury, thus owing to the increase in injury type segment for the ARDS market.

Key Players covered in this report are

Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech.

Device Type (Revenue in USD Million; Volume in Tons, 2016–2026)

• Monitoring Devices
• Diagnostic Devices
  • Blood Gas Analyzers
  • Pulse Oximeters
  • Spirometers
  • Capnography Devices
  • Other Diagnostic Devices
• Therapeutic Devices
  • Mechanical Ventilators
    • Invasive And Non-invasive Ventilators
  • Drug Delivery Devices
    • Nebulizers
    • Humidifiers
  • PAP
  • Other Therapeutic Devices

Injury Type (Revenue in USD Million; Volume in Tons, 2016–2026)

• Brain Injury
• Lung Injury

Severity (Revenue in USD Million; Volume in Tons, 2016–2026)

• Mild
• Moderate
• Severe

Treatment (Revenue in USD Million; Volume in Tons, 2016–2026)

• Fibro Proliferate
• Exudative Stage
• Resolution Stage
• Recovery Stage

Sales Channel (Revenue in USD Million; Volume in Tons, 2016–2026)

• Direct Sales
• Channel Sales

End User (Revenue in USD Million; Volume in Tons, 2016–2026)

• Hospitals
• Clinics
• Ambulatory Service Centers
• Other End Users

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

 

Major Points covered in this report are as below:

• In this report, market development trends and marketing channels in the Acute Respiratory Distress Syndrome (ARDS) industry are analyzed, feasibility of new investment projects is evaluated, and overall conclusions are presented.

• 
  This report provides key industry statistics through tables and figures, serving as an invaluable source of information and advice for companies and individuals involved in this sector.
• 
  Additionally, this report analyzes development policies and plans, manufacturing processes, and cost structures, as well as import/export consumption figures, supply and demand figures, costs, prices, revenues, and gross margins.
• 
  For companies and individuals interested in the Acute Respiratory Distress Syndrome (ARDS) industry, the Acute Respiratory Distress Syndrome (ARDS) Market report provides information on the current market status of the Acute Respiratory Distress Syndrome (ARDS) manufacturers and provides valuable guidance and direction.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

 

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2089

 

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report

 

Explore More Industry Research by Reports and Data:

Life Sciences Software Market @ https://www.biospace.com/article/life-sciences-software-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2028/

Periodontal Therapeutics Market @ https://www.biospace.com/article/periodontal-therapeutics-market-share-industry-growth-trend-drivers-challenges-key-companies-by-2028/

Cancer Biological Therapy Market @ https://www.biospace.com/article/cancer-biological-therapy-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2028/

Microscopy Devices Market @ https://www.biospace.com/article/microscopy-devices-market-share-comprehensive-analysis-opportunity-assessment-future-estimations-and-key-industry-segments-poised-for-strong-growth-in-future-2028/

 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

 

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs